Browsing by Author Wong, Kelly

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2014Factors determining pbsc mobilization efficiency and nonmobilization following ICE with or without rituximab (R-ICE) salvage therapy for refractory or relapsed lymphoma prior to autologous transplantationBai, Lijun; Greenwood, Matthew; Kerridge, Ian; Ma, Chun; Ward, Christopher; Xia, Wei; Reid, C.; Wong, Kelly; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; School of Public Health: Ctr for Values Ethics & Law in Med; Western Clinical School: Westmead Millennium Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling InstituteFactors determining pbsc mobilization efficiency and nonmobilization following ICE with or without rituximab (R-ICE) salvage therapy for refractory or relapsed lymphoma prior to autologous transplantation, Journal of Clinical Apheresis, vol.29, 6, 2014,pp 322-330
2014Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centreWard, Christopher; Bai, Lijun; Greenwood, Matthew; Reid, Cassandra; Wong, Kelly; Xia, Wei; Northern Clinical School: Kolling InstituteFactors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centre, Annals of Hematology, vol.93, 10, 2014,pp 1655-1664
2013Polyploidy in myelofibrosis: analysis by cytogenetic and SNP array indicates association with advancing diseaseSingh, Nisha; Stevenson, William; Ward, Christopher; Koleth, Mary; Morris, Christine; Wong, Kelly; Medicine Faculty Office; Northern Clinical School: Medicine; Northern Clinical School: Kolling InstitutePolyploidy in myelofibrosis: analysis by cytogenetic and SNP array indicates association with advancing disease, Molecular Cytogenetics, vol.6, 1, 2013,pp 1-12
2017Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantationGreenwood, Matthew; Kerridge, Ian; Stevenson, William; Arthur, Christopher; Coyle, Luke; Fay, Keith; Lindsay, Julian; Sandaradura, Indy; Wong, Kelly; Northern Clinical School: Kolling Institute; School of Public Health: Ctr for Values Ethics & Law in Med; Northern Clinical School: MedicineSerum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation, Journal of Antimicrobial Chemotherapy, vol.72, 12, 2017,pp 3414-3419